127 related articles for article (PubMed ID: 26647102)
1. Altered expression profile of apoptosis-related molecules correlated with clinicopathological factors in non-small-cell lung cancer.
Huang JQ; Liang HL; Jin TE; Xie Z
Int J Clin Exp Pathol; 2015; 8(9):11278-86. PubMed ID: 26647102
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
4. Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas.
Li Y; Xu KP; Jiang D; Zhao J; Ge JF; Zheng SY
Int J Clin Exp Pathol; 2015; 8(11):13978-86. PubMed ID: 26823709
[TBL] [Abstract][Full Text] [Related]
5. A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population.
Fan CF; Xu HT; Lin XY; Yu JH; Wang EH
Folia Histochem Cytobiol; 2011; 49(2):231-9. PubMed ID: 21744322
[TBL] [Abstract][Full Text] [Related]
6. Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
Stewart RL; West D; Wang C; Weiss HL; Gal T; Durbin EB; O'Connor W; Chen M; O'Connor KL
Hum Pathol; 2016 Aug; 54():174-83. PubMed ID: 27107458
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.
Sun SY; Yue P; Zhou JY; Wang Y; Choi Kim HR; Lotan R; Wu GS
Biochem Biophys Res Commun; 2001 Jan; 280(3):788-97. PubMed ID: 11162590
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of overexpressed matrix metalloproteinase-2, mouse-double minute: 2 homolog and epidermal growth factor receptor in non-small cell lung cancer.
Jiang LY; Bi R; Ding FB; Wang MS; Mei J; He Y
J BUON; 2016; 21(2):341-8. PubMed ID: 27273943
[TBL] [Abstract][Full Text] [Related]
9. Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer.
Liang JZ; Li YH; Zhang Y; Wu QN; Wu QL
Int J Clin Exp Pathol; 2015; 8(3):2937-45. PubMed ID: 26045802
[TBL] [Abstract][Full Text] [Related]
10. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer.
Qiu ZX; Zhao S; Mo XM; Li WM
Int J Clin Exp Pathol; 2015; 8(6):6589-95. PubMed ID: 26261540
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients.
Zhai L; Li S; Li H; Zheng Y; Lang R; Fan Y; Gu F; Guo X; Zhang X; Fu L
Int J Clin Exp Pathol; 2015; 8(6):7059-71. PubMed ID: 26261599
[TBL] [Abstract][Full Text] [Related]
13. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
14. Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer.
Michels J; Adam J; Goubar A; Obrist F; Damotte D; Robin A; Alifano M; Vitale I; Olaussen KA; Girard P; Cremer I; Castedo M; Soria JC; Kroemer G
Ann Oncol; 2015 Dec; 26(12):2470-7. PubMed ID: 26387143
[TBL] [Abstract][Full Text] [Related]
15. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
Gentles AJ; Bratman SV; Lee LJ; Harris JP; Feng W; Nair RV; Shultz DB; Nair VS; Hoang CD; West RB; Plevritis SK; Alizadeh AA; Diehn M
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26286589
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.
Cao X; Chen YZ; Luo RZ; Zhang L; Zhang SL; Zeng J; Jiang YC; Han YJ; Wen ZS
Oncotarget; 2015 May; 6(13):11704-13. PubMed ID: 25868976
[TBL] [Abstract][Full Text] [Related]
17. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
Ferreira CG; van der Valk P; Span SW; Ludwig I; Smit EF; Kruyt FA; Pinedo HM; van Tinteren H; Giaccone G
Clin Cancer Res; 2001 Aug; 7(8):2468-74. PubMed ID: 11489828
[TBL] [Abstract][Full Text] [Related]
18. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of Notch receptor signaling pathway induces caspase-dependent and caspase-independent apoptosis in lung squamous cell carcinoma cells.
Cao H; Hu Y; Wang P; Zhou J; Deng Z; Wen J
APMIS; 2012 Jun; 120(6):441-50. PubMed ID: 22583356
[TBL] [Abstract][Full Text] [Related]
20. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
